Pierre Fabre Pushes Open Innovation; Wants To Lead Onco-dermatology Field
This article was originally published in Scrip
Pierre Fabre Laboratories has signed a second deal providing a young biotech firm access to its phyto-chemical compound library under its open library program – just one enterprise the French pharmaceutical company has launched recently as part of its Open Innovation initiative, aimed at increasing access to biotech partners.
You may also be interested in...
A rush in the 2010s of high-tech and digital companies focused on women’s health and wellbeing are maturing, adding weight to the more traditional women's health market that has struggled to get attention from investors in the past.
An interactive look at recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.
A selection of articles you might have missed from September 2020, including exclusive interviews with industry leaders and a review of value-based contract approaches in the US.